Ranbaxy Drops After U.S. Blocks Import of 30 Drugs

" Ranbaxy Laboratories Ltd., India's biggest drugmaker, fell after the U.S. regulator blocked the sale of more than 30 generic medicines made in two factories by the company, because of deficiencies in manufacturing processes. Ranbaxy, being acquired by Japan's Daiichi...

US bans key Indian drug imports

After prolong investigations The US drug regulator FDA has banned top Indian Pharmaceuticals company Ranbaxy after latter was  found selling unsafe medicines in the country.US Department of Justice has...

closeSign in to NowPublic

is reporting from